感染性心内膜炎的管理考量:综述
该综述指出美国感染性心内膜炎发病率约15/10万且呈上升趋势,医疗相关病例占高收入国家三分之一,金黄色葡萄球菌为最常见病原体(可达40%)。诊断仍以超声心动图和血培养为主,辅助影像可提高敏感性;抗生素耐药增加需新药与联合方案,手术对严重并发症有生存获益但需权衡风险。
要点
- 高收入国家中金黄色葡萄球菌是感染性心内膜炎最常见病原体,可达40%。
- 超声心动图无结论时,心脏CT和核素显像可提高诊断敏感性。
- 血培养阴性时,血清学检查的诊断阳性率最高。
核心结论
- 感染性心内膜炎的流行病学和管理不断变化,指南提供具体推荐,但治疗决策需考虑患者个体特征、病原体和后遗症风险。
研究设计与样本
- 综述,基于美国感染性心内膜炎发病率约15/10万且 incidence 增加、医疗相关病例占高收入国家三分之一的背景。
主要发现
- 社区相关感染性心内膜炎仍为主要形式,但高收入国家医疗相关病例占三分之一。
- 心脏植入电子设备相关感染性心内膜炎发病率随老年患者医疗干预增加而上升。
- 过去十年年轻静脉吸毒者增加,美国住院比例增至超过10%。
- 高收入国家中金黄色葡萄球菌为最常见病原体,占病例高达40%。
- 抗生素耐药增加(尤其对金黄色葡萄球菌)需要新型抗生素和联合治疗方案。
关键数值与推荐
- 诊断主要依靠超声心动图和血培养。
- 超声心动图无结论时,心脏计算机断层扫描和核素显像可提高诊断敏感性。
- 血培养阴性时,血清学检查、组织病理学和聚合酶链反应检测各有作用,其中血清学检查阳性率最高。
- 手术可为有主要并发症的患者带来生存获益,但需权衡高风险患者的手术风险与获益。
临床怎么用
- 临床决策需综合患者个体特征、病原体及后遗症风险,并参考指南具体推荐。
局限性
- 原文未报告综述的检索范围、纳入研究数量或偏倚评估方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Infective endocarditis occurs in approximately 15 of 100 000 people in the United States and has increased in incidence. Clinicians must make treatment decisions with respect to prophylaxis, surgical management, specific antibiotics, and the length of treatment in the setting of emerging, sometimes inconclusive clinical research findings. OBSERVATIONS: Community-associated infective endocarditis remains the predominant form of the disease; however, health care accounts for one-third of cases in high-income countries. As medical interventions are increasingly performed on older patients, the disease incidence from cardiac implanted electronic devices is also increasing. In addition, younger patients involved with intravenous drug use has increased in the past decade and with it the proportion of US hospitalization has increased to more than 10%. These epidemiological factors have led to Staphylococcus aureus being the most common cause in high-income countries, accounting for up to 40% of cases. The mainstays of diagnosis are still echocardiography and blood cultures. Adjunctive imaging such as cardiac computed tomographic and nuclear imaging can improve the sensitivity for diagnosis when echocardiography is not conclusive. Serological studies, histopathology, and polymerase chain reaction assays have distinct roles in the diagnosis of infective endocarditis when blood culture have tested negative with the highest yield obtained from serological studies. Increasing antibiotic resistance, particularly to S aureus, has led to a need for different antibiotic treatment options such as newer antibiotics and combination therapy regimens. Surgery can confer a survival benefit to patients with major complications; however, the decision to pursue surgery must balance the risks and benefits of operations in these frequently high-risk patients. CONCLUSIONS AND RELEVANCE: The epidemiology and management of infective endocarditis are continually changing. Guidelines provide specific recommendations about management; however, careful attention to individual patient characteristics, pathogen, and risk of sequela must be considered when making therapeutic decisions.
引用
- Wang A, Gaca JG, Chu VH, et al. Management Considerations in Infective Endocarditis: A Review. JAMA. 2018. PMID: 29971402. doi:10.1001/jama.2018.7596
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。